Does MOLSIDOMINE Cause Dyspnoea? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Dyspnoea have been filed in association with MOLSIDOMINE. This represents 3.4% of all adverse event reports for MOLSIDOMINE.
13
Reports of Dyspnoea with MOLSIDOMINE
3.4%
of all MOLSIDOMINE reports
2
Deaths
12
Hospitalizations
How Dangerous Is Dyspnoea From MOLSIDOMINE?
Of the 13 reports, 2 (15.4%) resulted in death, 12 (92.3%) required hospitalization, and 3 (23.1%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOLSIDOMINE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does MOLSIDOMINE Cause?
Toxic epidermal necrolysis (84)
Blister (54)
Erythema (53)
Nausea (48)
Multiple organ dysfunction syndrome (45)
Respiratory disorder (44)
Diarrhoea (41)
Hypertension (37)
Cholecystitis (36)
Electrolyte imbalance (36)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which MOLSIDOMINE Alternatives Have Lower Dyspnoea Risk?
MOLSIDOMINE vs MOMELOTINIB
MOLSIDOMINE vs MOMETASONE
MOLSIDOMINE vs MOMETASONE FUROATE
MOLSIDOMINE vs MOMETASONE FUROATE\OLOPATADINE
MOLSIDOMINE vs MONOMETHYL